13 research outputs found

    Detection of a new Hainan gibbon (Nomascus hainanus) group using acoustic call playback

    Get PDF
    Targeted management actions informed by robust data are needed to conserve species of extreme rarity, and assessing the effectiveness of different field methods for detection and monitoring of such species is a conservation priority. Gibbons are typically detected by their daily song through passive listening surveys, but lone gibbon individuals and low-density populations are less likely to sing, making detection difficult or impossible using standard survey techniques. Call playback represents an alternative potential method for detecting gibbon presence, but there has been no empirical evaluation of the usefulness of this method in the field. We investigated the efficacy of call playback as a survey method for detecting previously unconfirmed or unknown individuals of the Critically Endangered Hainan gibbon (Nomascus hainanus), the world’s rarest primate, in patches of good-quality forest outside the current home ranges of the three known Hainan gibbon social groups in Bawangling National Nature Reserve, Hainan, China. Call playback led to detection of a male-only call likely to have been made by a solitary male, and a previously unknown social group comprising an adult male, adult female, and an infant, increasing the number of known breeding females in the global Hainan gibbon population from five to six. Call playback therefore represents an effective tool for improved monitoring of Hainan gibbons, as well as other gibbon populations; however, it is a moderately disruptive survey technique, and should be employed sparingly, in key locations, and for short periods of time only when attempting to detect gibbon presence

    Quaternary vertebrate faunas from Sumba, Indonesia: implications for Wallacean biogeography and evolution

    No full text
    Historical patterns of diversity, biogeography and faunal turnover remain poorly understood for Wallacea, the biologically and geologically complex island region between the Asian and Australian continental shelves. A distinctive Quaternary vertebrate fauna containing the small-bodied hominin Homo floresiensis, pygmy Stegodon proboscideans, varanids and giant murids has been described from Flores, but Quaternary faunas are poorly known from most other Lesser Sunda Islands. We report the discovery of extensive new fossil vertebrate collections from Pleistocene and Holocene deposits on Sumba, a large Wallacean island situated less than 50 km south of Flores. A fossil assemblage recovered from a Pleistocene deposit at Lewapaku in the interior highlands of Sumba, which may be close to 1 million years old, contains a series of skeletal elements of a very small Stegodon referable to S. sumbaensis, a tooth attributable to Varanus komodoensis, and fragmentary remains of unidentified giant murids. Holocene cave deposits at Mahaniwa dated to approximately 2000–3500 BP yielded extensive material of two new genera of endemic large-bodied murids, as well as fossils of an extinct frugivorous varanid. This new baseline for reconstructing Wallacean faunal histories reveals that Sumba's Quaternary vertebrate fauna, although phylogenetically distinctive, was comparable in diversity and composition to the Quaternary fauna of Flores, suggesting that similar assemblages may have characterized Quaternary terrestrial ecosystems on many or all of the larger Lesser Sunda Islands

    Text S1; Text S2; Text S3; Table S1; Table S2; Table S3; Table S4; Table S5 and Table S6 from Quaternary vertebrate faunas from Sumba, Indonesia: implications for Wallacean biogeography and evolution

    No full text
    Fossils and dating of <i>Stegodon sumbaensis</i>.; Systematic palaeontology.; Phylogenetic placement of <i>Milimonggamys</i> and <i>Raksasamys</i>.; Caves on Sumba investigated for Quaternary fossils.; Toothrow lengths and mass estimates for Lesser Sunda murids.; Morphological character matrix of southeast Asian murids.; Maxillary tooth measurements for <i>Varanus hooijeri</i>.; Uranium-series isotope data from line analyses of <i>Stegodon</i> molar.; Uranium-series isotope data from spot analyses of Stegodon molar

    Integrated genomic and transcriptomic analysis of human brain metastases identifies recurrently altered pathways of potential clinical significance

    No full text
    Treatment options for patients with brain metastases (BMs) have limited efficacy and the mortality rate is virtually 100%. Targeted therapy is critically under-utilized, and our understanding of mechanisms underpinning metastatic outgrowth in the brain is limited. To address these deficiencies, we investigated the genomic and transcriptomic landscapes of 36 BMs from breast, lung, melanoma and oesophageal cancers, using DNA copy-number analysis and exome- and RNA-sequencing. The key findings were as follows. (a) Identification of novel candidates with possible roles in BM development, including the significantly mutated genes DSC2, ST7, PIK3R1 and SMC5, and the DNA repair, ERBB-HER signalling, axon guidance and protein kinase-A signalling pathways. (b) Mutational signature analysis was applied to successfully identify the primary cancer type for two BMs with unknown origins. (c) Actionable genomic alterations were identified in 31/36 BMs (86%); in one case we retrospectively identified ERBB2 amplification representing apparent HER2 status conversion, then confirmed progressive enrichment for HER2-positivity across four consecutive metastatic deposits by IHC and SISH, resulting in the deployment of HER2-targeted therapy for the patient. (d) In the ERBB/HER pathway, ERBB2 expression correlated with ERBB3 (r = 0.496; p < 0.0001) and HER3 and HER4 were frequently activated in an independent cohort of 167 archival BM from seven primary cancer types: 57.6% and 52.6% of cases were phospho-HER3 or phospho-HER4 membrane-positive, respectively. The HER3 ligands NRG1/2 were barely detectable by RNAseq, with NRG1 (8p12) genomic loss in 63.6% breast cancer-BMs, suggesting a microenvironmental source of ligand. In summary, this is the first study to characterize the genomic landscapes of BM. The data revealed novel candidates, potential clinical applications for genomic profiling of resectable BMs, and highlighted the possibility of therapeutically targeting HER3, which is broadly over-expressed and activated in BMs, independent of primary site and systemic therapy
    corecore